These results provide further evidence that a “normal” serum ALT level provides little diagnostic or prognostic value when assessing patients for NAFLD, as suggested by a previous study by Targher et al.33 indicating that approximately four fifths (~80%) of patients with T1DM and NAFLD had serum ALT levels within the reference range. The gene discussed is GPT; the disease is type 1 diabetes mellitus.